AAAAAA
Results: 1-25/50
Authors:
Niemela, M
Maenpaa, H
Salven, P
Summanen, P
Poussa, K
Laatikainen, L
Jaaskelainen, J
Joensuu, H
Citation: M. Niemela et al., Interferon alpha-2a therapy in 18 hemangioblastomas, CLIN CANC R, 7(3), 2001, pp. 510-516
Authors:
Rantanen, S
Monni, O
Joensuu, H
Franssila, K
Knuutila, S
Citation: S. Rantanen et al., Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma, LEUK LYMPH, 42(5), 2001, pp. 1089-1098
Authors:
Zhu, Y
Loukola, A
Monni, O
Kuokkanen, K
Franssila, K
Elonen, E
Vilpo, J
Joensuu, H
Kere, J
Aaltonen, L
Knuutila, S
Citation: Y. Zhu et al., PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas, LEUK LYMPH, 41(1-2), 2001, pp. 177-183
Authors:
Rummukainen, JK
Salminen, T
Lundin, J
Kytola, S
Joensuu, H
Isola, JJ
Citation: Jk. Rummukainen et al., Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array, MOD PATHOL, 14(10), 2001, pp. 1030-1035
Authors:
Salven, P
Anttonen, K
Repo, H
Joensuu, H
Orpana, A
Citation: P. Salven et al., Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells, FASEB J, 15(7), 2001, pp. 1318-1320
Authors:
Joensuu, H
Dimitrijevic, S
Citation: H. Joensuu et S. Dimitrijevic, Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours, ANN MED, 33(7), 2001, pp. 451-455
Authors:
Lundin, J
Lundin, M
Holli, K
Kataja, V
Elomaa, L
Pylkkanen, L
Turpeenniemi-Hujanen, T
Joensuu, H
Citation: J. Lundin et al., Omission of histologic grading from clinical decision making may result inoveruse of adjuvant therapies in breast cancer: Results from a nationwide study, J CL ONCOL, 19(1), 2001, pp. 28-36
Authors:
Nyandoto, P
Muhonen, T
Hakala, T
Dombrowski, MP
Joensuu, H
Citation: P. Nyandoto et al., Financial compensation for radiotherapy-related adverse events in a judicial system where proof of medical negligence is not required, INT J RAD O, 51(1), 2001, pp. 209-212
Authors:
Makkonen, T
Tuominen, J
Joensuu, H
Citation: T. Makkonen et al., Comment on: Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study - In Response, INT J RAD O, 50(5), 2001, pp. 1373-1374
Authors:
Poikonen, P
Blomqvist, C
Joensuu, H
Citation: P. Poikonen et al., Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area, ACTA ONCOL, 40(1), 2001, pp. 67-71
Authors:
Jukkola, A
Bloigu, R
Holli, K
Joensuu, H
Valavaara, R
Risteli, J
Blanco, G
Citation: A. Jukkola et al., Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer, ANTICANC R, 21(4B), 2001, pp. 2873-2876
Authors:
Anttonen, A
Heikkila, P
Kajanti, M
Jalkanen, M
Joensuu, H
Citation: A. Anttonen et al., High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery, LUNG CANC, 32(3), 2001, pp. 297-305
Authors:
Sjostrom, J
Alfthan, H
Joensuu, H
Stenman, UH
Lundin, J
Blomqvist, C
Citation: J. Sjostrom et al., Serum tumour markers CA 15-3, TPA, TPS, hCG beta and TATI in the monitoring of chemotherapy response in metastatic breast cancer, SC J CL INV, 61(6), 2001, pp. 431-441
Authors:
Osterlund, P
Elomaa, I
Virkkunen, P
Joensuu, H
Citation: P. Osterlund et al., A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer, ONCOL-BASEL, 61(2), 2001, pp. 113-119
Authors:
Joensuu, H
Roberts, PJ
Sarlomo-Rikala, M
Andersson, LC
Tervahartiala, P
Tuveson, D
Silberman, SL
Capdeville, R
Dimitrijevic, S
Druker, B
Demetri, GD
Citation: H. Joensuu et al., Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor., N ENG J MED, 344(14), 2001, pp. 1052-1056
Authors:
Rummukainen, JK
Salminen, T
Lundin, J
Joensuu, H
Isola, JJ
Citation: Jk. Rummukainen et al., Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples, LAB INV, 81(11), 2001, pp. 1545-1551
Authors:
Hemminki, A
Joensuu, H
Citation: A. Hemminki et H. Joensuu, Microsatellite instability as a molecular marker for very good survival incolorectal cancer patients receiving adjuvant chemotherapy - Reply, GASTROENTY, 120(5), 2001, pp. 1309-1310
Authors:
Holli, K
Saaristo, R
Isola, J
Joensuu, H
Hakama, M
Citation: K. Holli et al., Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study, BR J CANC, 84(2), 2001, pp. 164-169
Authors:
Hemmer, S
Wasenius, VM
Haglund, C
Zhu, Y
Knuutila, S
Franssila, K
Joensuu, H
Citation: S. Hemmer et al., Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations inparathyroid adenomas, AM J PATH, 158(4), 2001, pp. 1355-1362
Authors:
Maenpaa, H
Ristamaki, R
Virtamo, J
Franssila, K
Albanes, D
Joensuu, H
Citation: H. Maenpaa et al., Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma, LEUK LYMPH, 37(5-6), 2000, pp. 585-592
Authors:
Poikonen, P
Saarto, T
Elomaa, I
Joensuu, H
Blomqvist, C
Citation: P. Poikonen et al., Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancerpatients, EUR J CANC, 36(1), 2000, pp. 43-48
Authors:
Ruotsalainen, T
Halme, M
Isokangas, OP
Pyrhonen, S
Mantyla, M
Pekonen, M
Sarna, S
Joensuu, H
Mattson, K
Citation: T. Ruotsalainen et al., Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer - a feasibility study, ANTI-CANC D, 11(2), 2000, pp. 101-108
Authors:
Joensuu, H
Citation: H. Joensuu, Novel cancer therapies: more efficacy, less toxicity and improved organ preservation, ANN MED, 32(1), 2000, pp. 31-33
Authors:
Holli, K
Valavaara, R
Blanco, G
Kataja, V
Hietanen, P
Flander, M
Pukkala, E
Joensuu, H
Citation: K. Holli et al., Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3487-3494
Authors:
Zhu, Y
Monni, O
Franssila, K
Elonen, E
Vilpo, J
Joensuu, H
Knuutila, S
Citation: Y. Zhu et al., Deletions at 11q23 in different lymphoma subtypes, HAEMATOLOG, 85(9), 2000, pp. 908-912